| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Takeichi T et al. | Darier's Disease Complicated by Schizophrenia Caused by a Novel ATP2A2 Mutation. | 2016 | Acta Derm. Venereol. | pmid:27025976 |
| Nomura T et al. | Punctate palmoplantar keratoderma type 1: a novel AAGAB mutation and efficacy of etretinate. | 2015 | Acta Derm. Venereol. | pmid:24573067 |
| Ortiz NE et al. | Acitretin. | 2013 Sep-Oct | Dermatol Ther | pmid:24099069 |
| Digiovanna JJ et al. | Systemic retinoids in the management of ichthyoses and related skin types. | 2013 Jan-Feb | Dermatol Ther | pmid:23384018 |
| Davis SA et al. | Acitretin prescribing patterns in women of childbearing potential. | 2013 | J Drugs Dermatol | pmid:23884494 |
| Ueo D et al. | Late-onset Darier's disease due to a novel missense mutation in the ATP2A2 gene: a different missense mutation affecting the same codon has been previously reported in acrokeratosis verruciformis. | 2013 | J. Dermatol. | pmid:23289714 |
| Miyagaki T et al. | Oral erosive lichen planus associated with thymoma treated with etretinate. | 2013 | Australas. J. Dermatol. | pmid:23373893 |
| Inoue T et al. | Vitamin A treatment for psoriasis vulgaris in a dialysis patient. | 2013 | Am. J. Kidney Dis. | pmid:24011973 |
| Akasaka E et al. | Long-term efficacy of psoriasis vulgaris treatments: analysis of treatment with topical corticosteroid and/or vitamin D3 analog, oral cyclosporin, etretinate and phototherapy over a 35-year period, 1975-2010. | 2013 | J. Dermatol. | pmid:23330814 |
| Nakamura S et al. | Primary cutaneous CD30+ lymphoproliferative disorder successfully treated by etretinate. | 2012 Sep-Oct | Eur J Dermatol | pmid:22929532 |
| Umezawa Y et al. | Generalized pustular psoriasis in a child: observation of long-term combination therapy with etretinate and calcipotriol for 16 years. | 2012 Mar-Apr | Pediatr Dermatol | pmid:22409471 |
| Vena GA and Cassano N | The effects of alcohol on the metabolism and toxicology of anti-psoriasis drugs. | 2012 | Expert Opin Drug Metab Toxicol | pmid:22594656 |
| Yamamoto M et al. | Case of epidermolytic ichthyosis (bullous congenial ichthyosiform erythroderma) with a novel L157P mutation in KRT10 complicated by hypercalcemia. | 2012 | J. Dermatol. | pmid:22035476 |
| Shin SY et al. | Blood donors on teratogenic drugs and donor deferral periods in a clinical situation. | 2012 | Vox Sang. | pmid:22211799 |
| Yamamoto M et al. | Severe generalized pustular psoriasis accompanied by bullae formation with increased serum vascular endothelial growth factor level. | 2012 | J. Dermatol. | pmid:21767290 |
| Tourlaki A et al. | Genetically proven Mal de Meleda complicated by Bowen's disease of the sole. | 2011 Mar-Apr | Eur J Dermatol | pmid:21382790 |
| Gutierrez-Mazariegos J et al. | Vitamin A: a multifunctional tool for development. | 2011 | Semin. Cell Dev. Biol. | pmid:21693195 |
| Wakamatsu K et al. | Psoriasis verrucosa. | 2010 | J. Dermatol. | pmid:21083712 |
| Tsuji S et al. | Case report: psoriatic erythroderma with bilateral osseous bridge across the acetabulum. | 2010 | Clin. Orthop. Relat. Res. | pmid:19657703 |
| Senba-Nakata K et al. | Etretinate combined with low-dose prednisolone for an aged patient with adult T-cell leukaemia/lymphoma. | 2010 | Clin. Exp. Dermatol. | pmid:19925487 |
| Seishima M et al. | Photoleukomelanoderma possibly caused by etretinate in a patient with psoriasis. | 2010 | Acta Derm. Venereol. | pmid:20107735 |
| Abbott RA and Griffiths WA | Pityriasis rubra pilaris type 1 spontaneously resolving after 20 years. | 2009 | Clin. Exp. Dermatol. | pmid:19309372 |
| Lin MH et al. | Sequential systemic retinoid and photodynamic therapy for multiple keratotic pigmented nodular basal cell carcinomas on the scalp. | 2009 | J. Dermatol. | pmid:19712282 |
| Ishida N et al. | Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy. | 2009 | Clin. Exp. Dermatol. | pmid:19077103 |
| Nakashima H et al. | Cutaneous gamma/delta T-cell lymphoma treated with retinoid and narrowband ultraviolet B. | 2009 | Clin. Exp. Dermatol. | pmid:19456763 |
| Park HD et al. | A fully validated HPLC method for the simultaneous determination of acitretin and etretinate in plasma and its application to a pharmacokinetic study in healthy Korean subjects. | 2009 | Int J Clin Pharmacol Ther | pmid:19640355 |
| Stosić-Grujicić S et al. | Retinoids differentially regulate the progression of autoimmune diabetes in three preclinical models in mice. | 2009 | Mol. Immunol. | pmid:19211146 |
| Macbeth AE and Johnston GA | Twenty-one years of oral retinoid therapy in siblings with nonbullous ichthyosiform erythroderma. | 2008 | Clin. Exp. Dermatol. | pmid:17927786 |
| Park HD et al. | Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions. | 2008 | Transfusion | pmid:18657077 |
| Liu X et al. | Comparison of the in vitro and in vivo effects of retinoids either alone or in combination with cisplatin and 5-fluorouracil on tumor development and metastasis of melanoma. | 2008 | Cancer Chemother. Pharmacol. | pmid:18465132 |
| Ishiura N et al. | A case of milia en plaque successfully treated with oral etretinate. | 2007 | Br. J. Dermatol. | pmid:17927794 |
| Goodemote P et al. | Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis? | 2007 | J Fam Pract | pmid:17976342 |
| Komatsu N et al. | Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy. | 2007 | Br. J. Dermatol. | pmid:17459012 |
| Saba NF et al. | Moving toward bioadjuvant approaches to head and neck cancer prevention. | 2007 | Int. J. Radiat. Oncol. Biol. Phys. | pmid:17848282 |
| Halverstam CP et al. | Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature. | 2006 Nov-Dec | J Cutan Med Surg | pmid:17241599 |
| Mashiko M et al. | Bacterial infection-induced generalized Hailey-Hailey disease successfully treated by etretinate. | 2006 | Clin. Exp. Dermatol. | pmid:16309483 |
| Kano Y et al. | Dramatic improvement of psoriatic erythroderma after acute hepatitis: analysis of cytokine synthesis capability in peripheral blood T cells. | 2006 | Br. J. Dermatol. | pmid:16882189 |
| Katugampola RP and Finlay AY | Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients. | 2006 | Br. J. Dermatol. | pmid:16433796 |
| Asano K et al. | Fibrodysplasia ossificans progressiva-like condition in a cat. | 2006 | J. Vet. Med. Sci. | pmid:17019075 |
| Marquart JD et al. | Human papillomavirus 57-induced extensive, recalcitrant cutaneous verrucae. | 2006 | J. Am. Acad. Dermatol. | pmid:17052505 |
| Okuyama R and Tagami H | Psoriasis verrucosa in an obese Japanese man; a prompt clinical response observed with oral etretinate. | 2006 | J Eur Acad Dermatol Venereol | pmid:17062076 |
| Asano Y et al. | Generalized granuloma annulare treated with short-term administration of etretinate. | 2006 | J. Am. Acad. Dermatol. | pmid:16631959 |
| Akiyama M et al. | Compound heterozygous mutations including a de novo missense mutation in ABCA12 led to a case of harlequin ichthyosis with moderate clinical severity. | 2006 | J. Invest. Dermatol. | pmid:16675967 |
| Yanagi T et al. | Epidermodysplasia verruciformis and generalized verrucosis: the same disease? | 2006 | Clin. Exp. Dermatol. | pmid:16681585 |
| Gordon KB and Ruderman EM | The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach. | 2006 | J. Am. Acad. Dermatol. | pmid:16488334 |
| Inozume T et al. | Successful use of etretinate for long-term management of a patient with cutaneous-type adult T-cell leukaemia/lymphoma. | 2005 | Br. J. Dermatol. | pmid:16307674 |
| Seishima M et al. | Thrombocytopenia possibly induced by etretinate in a psoriatic patient. | 2005 | J. Dermatol. | pmid:16361755 |
| Ikeda T et al. | The effects of vitamin A derivative etretinate on the skin of MRL mice. | 2005 | Lupus | pmid:16130505 |
| Yamamoto T et al. | Evaluation of psoriatic patients with HCV infection. | 2005 | J. Dermatol. | pmid:16361725 |
| Bukhari IA | Impetigo herpetiformis in a primigravida: successful treatment with etretinate. | 2004 Jul-Aug | J Drugs Dermatol | pmid:15303793 |
Etretinate
Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.
Cross Reference
Introduction
To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Etretinate?
Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Etretinate
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Etretinate?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Etretinate?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Etretinate?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Etretinate?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Etretinate?
There are no associated biomedical information in the current reference collection.